High-content imaging analysis was performed to quantify cell viability and conformational changes of tau within MAP2-labeled neurons detected by the MC1 antibody (Fig. 1g), which detects a pathological conformation of tau species in the brains of AD patients, but not in healthy controls46. Here, MAP2 is linked to Alzheimer disease.